IP Considerations Relating To Antibody Drug Conjugates (ADC) скачать в хорошем качестве

IP Considerations Relating To Antibody Drug Conjugates (ADC)

It is a pleasure hosting Dr. Julia Minitti of Wilson Sonsini Goodrich & Rosati at our SPEAKERS SERIES at Emery Pharma. Julia is a partner at Wilson Sonsini Goodrich & Rosati in their Palo Alto office. She specializes in patent and innovation strategies, primarily serving clients in the biotechnology, chemical, and pharmaceutical industries. Her work encompasses patent portfolio development and management, Orange Book listings, patentability assessments, non-infringement and freedom-to-operate opinions, and intellectual property aspects of transactions like mergers and acquisitions, licenses, and venture financings. Julia's educational background includes a J.D. from Santa Clara University School of Law, a Ph.D. in Organic Chemistry from Brown University, and a B.S. in Chemistry from Union College, At Wilson Sonsini, Julia also serves as co-chair of the firm's hiring committee and the patent and innovations group, indicating her leadership role within the firm. About Emery Pharma: Emery Pharma is deeply committed to advancing public health and exclusively focuses on projects that enhance the well-being of both individuals and the environment. As a comprehensive contract research laboratory, Emery Pharma provides extensive support across the entire spectrum of pharmaceutical development, covering small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more. Emery Pharma's array of premium services includes analytical and bioanalytical solutions, microbiology and cell biology services, drug and impurity characterization, and comprehensive R&D with cGMP/GLP support. The Emery Pharma team excels in customizing innovative solutions tailored to the unique requirements of each client. They seamlessly oversee the entire process, from initial drug discovery to thorough data analysis and insights generation. Their expertise allows them to tackle scientific challenges proactively, ensuring clients avoid unnecessary setbacks. Emery Pharma's accomplished chemists and biologists harness state-of-the-art technology, encompassing cutting-edge tools such as high-resolution mass spectrometry (Orbitrap), triple quad LC-MS/MS, GC-MS, preparative HPLC, and 400 MHz multinuclear NMR. For further details, please don't hesitate to reach out to Emery Pharma at info@emerypharma.com or explore their website at: https://emerypharma.com/